Showing results (131-140 of 3,316) with videos related to
Sort By:
Pageof 332
Journal of Clinical Psychopharmacology|December 31, 2010
Lamotrigine in the immediate treatment of outpatients with depersonalization disorder without psychiatric comorbidity: randomized, double-blind, placebo-controlled studyNadir A Aliyev, Zafar N AliyevJournal of Clinical Psychopharmacology|December 31, 2010
Antidepressant exposure as a predictor of clinical outcomes in the Treatment of Resistant Depression in Adolescents (TORDIA) studyDara J Sakolsky, James M Perel, Graham J Emslie, et al.Journal of Clinical Psychopharmacology|December 31, 2010
Antidepressant drugs in children and adolescents: analytical and demographic data in a naturalistic, clinical studyMaria D Chermá, Johan Ahlner, Finn Bengtsson, et al.Journal of Clinical Psychopharmacology|December 31, 2010
Pseudohypoalgesia on the skin: a novel view on the paradox of pain perception in depressionKarl-Jürgen Bär, Janneke Terhaar, Michael Karl Boettger, et al.Journal of Clinical Psychopharmacology|June 1, 1990
Tourette syndrome: a follow-up studyP Sandor, S Musisi, H Moldofsky, et al.Journal of Clinical Psychopharmacology|June 1, 1990
Treatment of depersonalization with serotonin reuptake blockersE Hollander, M R Liebowitz, C DeCaria, et al.Journal of Clinical Psychopharmacology|October 1, 1990
Disposition of bupropion in healthy volunteers and subjects with alcoholic liver diseaseC L DeVane, S C Laizure, J T Stewart, et al.Journal of Clinical Psychopharmacology|June 24, 2010
Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese populationYiru Fang, Chengmei Yuan, Yifeng Xu, et al.Journal of Clinical Psychopharmacology|June 24, 2010
The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholicsHugh Myrick, Xingbao Li, Patrick K Randall, et al.Journal of Clinical Psychopharmacology|June 24, 2010
A post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus haloperidol followed by a 3-year double-blind extension trialStephen M Stahl, Ashok Malla, John W Newcomer, et al.Pageof 332